Steven J Soldin1, Offie P Soldin. 1. Department of Medicine, Georgetown University, Washington, DC 20007, USA. sjs44@georgetown.edu
Abstract
BACKGROUND: New high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) methods are among the most successful approaches to improve specificity problems inherent in many immunoassays. CONTENT: We emphasize problems with immunoassays for the measurement of steroids and review the emerging role of LC-MS/MS in the measurement of clinically relevant steroids. The latest generation of tandem mass spectrometers has superior limits of quantification, permitting omission of previously employed derivatization steps. The measurement of steroid profiles in the diagnosis and treatment of congenital adrenal hyperplasia, adrenal insufficiency, chronic pelvic pain and prostatitis, oncology (breast cancer), and athletes has important new applications. CONCLUSIONS: LC-MS/MS now affords the specificity, imprecision, and limits of quantification necessary for the reliable measurement of steroids in human fluids, enhancing diagnostic capabilities, particularly when steroid profiles are available.
BACKGROUND: New high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) methods are among the most successful approaches to improve specificity problems inherent in many immunoassays. CONTENT: We emphasize problems with immunoassays for the measurement of steroids and review the emerging role of LC-MS/MS in the measurement of clinically relevant steroids. The latest generation of tandem mass spectrometers has superior limits of quantification, permitting omission of previously employed derivatization steps. The measurement of steroid profiles in the diagnosis and treatment of congenital adrenal hyperplasia, adrenal insufficiency, chronic pelvic pain and prostatitis, oncology (breast cancer), and athletes has important new applications. CONCLUSIONS: LC-MS/MS now affords the specificity, imprecision, and limits of quantification necessary for the reliable measurement of steroids in human fluids, enhancing diagnostic capabilities, particularly when steroid profiles are available.
Authors: M Hill; M Bicíková; A Parízek; H Havlíková; J Klak; T Fajt; M Meloun; D Cibula; A Cegan; J Sulcová; R Hampl; L Stárka Journal: J Steroid Biochem Mol Biol Date: 2001-07 Impact factor: 4.292
Authors: Joanne F Dorgan; Thomas R Fears; Robert P McMahon; Lisa Aronson Friedman; Blossom H Patterson; Susan F Greenhut Journal: Steroids Date: 2002-03 Impact factor: 2.668
Authors: M Hill; A Parízek; M Bicíková; H Havlíková; J Klak; T Fait; D Cibula; R Hampl; A Cegan; J Sulcová; L Stárka Journal: J Steroid Biochem Mol Biol Date: 2000-12-31 Impact factor: 4.292
Authors: Ming Zhao; Sharyn D Baker; Xiaohua Yan; Yiyu Zhao; William W Wright; Barry R Zirkin; Jonathan P Jarow Journal: Steroids Date: 2004 Oct-Nov Impact factor: 2.668
Authors: Diane S Thompson; Margaret A Kirshner; Thomas L Klug; Kari B Kastango; Bruce G Pollock Journal: Ther Drug Monit Date: 2003-02 Impact factor: 3.681
Authors: Daniel J Haisenleder; Aleisha H Schoenfelder; Elizabeth S Marcinko; Lisa M Geddis; John C Marshall Journal: Endocrinology Date: 2011-09-20 Impact factor: 4.736
Authors: Brian R Stolze; Verena Gounden; Jianghong Gu; Elizabeth A Elliott; Likhona S Masika; Brent S Abel; Deborah P Merke; Monica C Skarulis; Steven J Soldin Journal: J Steroid Biochem Mol Biol Date: 2015-12-22 Impact factor: 4.292
Authors: Jordan N Kohn; Noah Snyder-Mackler; Luis B Barreiro; Zachary P Johnson; Jenny Tung; Mark E Wilson Journal: Psychoneuroendocrinology Date: 2016-09-12 Impact factor: 4.905
Authors: Nils Krone; Beverly A Hughes; Gareth G Lavery; Paul M Stewart; Wiebke Arlt; Cedric H L Shackleton Journal: J Steroid Biochem Mol Biol Date: 2010-04-22 Impact factor: 4.292